<code id='72F8902C19'></code><style id='72F8902C19'></style>
    • <acronym id='72F8902C19'></acronym>
      <center id='72F8902C19'><center id='72F8902C19'><tfoot id='72F8902C19'></tfoot></center><abbr id='72F8902C19'><dir id='72F8902C19'><tfoot id='72F8902C19'></tfoot><noframes id='72F8902C19'>

    • <optgroup id='72F8902C19'><strike id='72F8902C19'><sup id='72F8902C19'></sup></strike><code id='72F8902C19'></code></optgroup>
        1. <b id='72F8902C19'><label id='72F8902C19'><select id='72F8902C19'><dt id='72F8902C19'><span id='72F8902C19'></span></dt></select></label></b><u id='72F8902C19'></u>
          <i id='72F8902C19'><strike id='72F8902C19'><tt id='72F8902C19'><pre id='72F8902C19'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:fashion    Page View:931
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          State Dept. review finds Biden bears some blame for Afghanistan failures
          State Dept. review finds Biden bears some blame for Afghanistan failures

          3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

          read more
          Study: New antibiotic targets gonorrhea as well as last existing drug
          Study: New antibiotic targets gonorrhea as well as last existing drug

          ColorizedscanningelectronmicrographofNeisseriagonorrhoeaebacteria,whichcausesgonorrhea.NIAIDAnimport

          read more
          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more

          World's first CRISPR

          BillSikes/APLONDON—RegulatorsintheU.K.onThursdayapprovedaCRISPR-basedmedicinetotreatbothsicklecelldi